Compounds > deamino-arginine-vasopressin

deamino-arginine-vasopressin and Hyphema

deamino-arginine-vasopressin has been researched along with Hyphema* in 1 studies

Other Studies

1 other study(ies) available for deamino-arginine-vasopressin and Hyphema

Article	Year
Pitfalls in the management of a child with mild haemophilia A and a traumatic hyphaema. Haemophilia : the official journal of the World Federation of Hemophilia, 2000, Volume: 6, Issue:2 A 12-year-old boy presented with a traumatic hyphaema that failed to settle with the standard treatment. Subsequent investigation showed that despite a normal APTT, he had a low factor VIII:C. Treatment with DDAVP precipitated further bleeding despite correction of the fVIII:C to normal, possibly caused by the vasodilation induced by the therapy. Bleeding was effectively treated with recombinant fVIII concentrate. DDAVP may be contraindicated in mild Haemophilia and von Willebrand patients for treatment of traumatic hyphaema. Topics: Child; Contraindications; Deamino Arginine Vasopressin; Disease Management; Factor VIII; Hemophilia A; Hemostatics; Humans; Hyphema; Male; Partial Thromboplastin Time; Recombinant Proteins; Wounds and Injuries	2000

Article

Year

Pitfalls in the management of a child with mild haemophilia A and a traumatic hyphaema.

Haemophilia : the official journal of the World Federation of Hemophilia, 2000, Volume: 6, Issue:2

A 12-year-old boy presented with a traumatic hyphaema that failed to settle with the standard treatment. Subsequent investigation showed that despite a normal APTT, he had a low factor VIII:C. Treatment with DDAVP precipitated further bleeding despite correction of the fVIII:C to normal, possibly caused by the vasodilation induced by the therapy. Bleeding was effectively treated with recombinant fVIII concentrate. DDAVP may be contraindicated in mild Haemophilia and von Willebrand patients for treatment of traumatic hyphaema.

Topics: Child; Contraindications; Deamino Arginine Vasopressin; Disease Management; Factor VIII; Hemophilia A; Hemostatics; Humans; Hyphema; Male; Partial Thromboplastin Time; Recombinant Proteins; Wounds and Injuries

2000